Table 1:
Baseline demographic data and laboratory results in study groups
| Characteristics | Cyproheptadine group (n=40) Mean (SD) | Placebo Group (n=37) Mean (SD) | P. value |
|---|---|---|---|
| Age (month) | 40.08 (11.24) | 44.30 (12.05) | 0.117 |
| Weight (kg) | 11.93 (1.58) | 12.31 (1.68) | 0.304 |
| Height (cm) | 92.35 (6.93) | 93.84 (6.89) | 0.348 |
| Body mass index (kg/m2) | 13.97 (0.81) | 13.95 (0.74) | 0.900 |
| Bone age (year) | 2.64 (0.79) | 2.93 (0.78) | 0.117 |
| White blood count (cell/mm3) | 8260 (266) | 8040 (250) | 0.743 |
| Hemoglobin (g/dL) | 12.20 (1.23) | 12.57 (0.82) | 0.121 |
| Fasting blood sugar (mg/dL) | 80.78 (8.90) | 79.32 (8.30) | 0.230 |
| Albumin (g/dL) | 4.50 (0.26) | 4.45 (0.26) | 0.439 |
| Calcium (mg/dL) | 9.30 (0.62) | 9.44 (0.62) | 0.318 |
| Phosphorus (mg/dL) | 5.09 (0.87) | 4.87 (0.85) | 0.249 |
SD: Standard Deviation